Drug Shortage Report for APO-TERBINAFINE

Last updated on 2020-08-10 History
Report ID 75632
Drug Identification Number 02239893
Brand name APO-TERBINAFINE
Common or Proper name TERBINAFINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) TERBINAFINE
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30BLS and 100 BTL
ATC code D01BA
ATC description ANTIFUNGALS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-02-11
Estimated end date 2020-08-21
Actual end date 2020-08-07
Shortage status Resolved
Updated date 2020-08-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-02-13 English Compare
v2 2019-02-13 French Compare
v3 2019-04-26 English Compare
v4 2019-04-26 French Compare
v5 2019-05-31 English Compare
v6 2019-05-31 French Compare
v7 2020-04-14 English Compare
v8 2020-04-14 French Compare
v9 2020-05-27 English Compare
v10 2020-05-27 French Compare
v11 2020-08-10 English Compare
v12 2020-08-10 French Compare

Showing 1 to 12 of 12